ArticleVeterinary surgery : VS2026
Clinical presentation, treatment, and outcomes for 15 dogs with two or three congenital extrahepatic portosystemic shunts.
Article in Veterinary surgery : VS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical presentation, treatment, and outcomes for 15 dogs with two or three congenital extrahepatic portosystemic shunts.Veterinary surgery : VS · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo assess clinical presentation, treatment, and outcomes of dogs with two or three congenital extrahepatic portosystemic shunts (M-EHPSS). STUDY
designMulti-institutional retrospective study. SAMPLE POPULATION: A total of 15 dogs with M-EHPSS.
methodsMedical records were reviewed, and data was collected on dogs with M-EHPSS diagnosed via computed tomography (CT) between 2008 and 2024. Signalment, clinical signs, bloodwork values, postoperative complications, long-term clinical outcome, survival, and owner reported quality of life were recorded.
resultsApproximately half of the dogs (7/15; 47%) were Miniature Schnauzers. Clinical signs and hematologic indicators at presentation were comparable to EHPSS. The mean dog age at diagnosis via CT imaging was 1451 days, and all dogs underwent surgical attenuation (SA) except for one that was ultimately lost to follow up examination. A total of 12 dogs had two shunts, and three dogs had three shunts. Seven dogs did not undergo attenuation of one shunt; these other shunts were either not initially suspected (5/7), the attenuation device was misplaced (1/7) or surgeon preference to not place attenuation device (1/7). Left gastro-phrenic EHPSS were the only EHPSS not suspected initially. At the time of last follow-up (median: 1253 days), 10/15 dogs were alive. Clinical outcomes were good or excellent in most dogs (12/14; 86%).
conclusionThese findings suggest that M-EHPSS dogs have a similar prognosis to dogs with standard EHPSS dogs when all EHPSS are identified and treated with appropriate attenuation placement. A potential breed predisposition towards Miniature Schnauzers was identified. CLINICAL SIGNIFICANCE: This information provides guidance for treatment and prognosis of dogs with M-EHPSS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.